Chinese Journal of Stroke ›› 2020, Vol. 15 ›› Issue (09): 934-941.DOI: 10.3969/j.issn.1673-5765.2020.09.003
Previous Articles Next Articles
Received:
2020-06-30
Online:
2020-09-20
Published:
2020-09-20
刘慧慧,姜倩梅,戴婧,刘春风
通讯作者:
刘春风 liuchunfeng@suda.edu.cn
基金资助:
国家自然科学基金(81701149)
江苏省医学重点学科(ZDXKB2016022)
苏州市临床医学中心立项项目(Szzx201503)
LIU Hui-Hui, JIANG Qian-Mei, DAI Jing,LIU Chun-Feng. Advances in Intravenous Thrombolysis for Acute Ischemic Stroke[J]. Chinese Journal of Stroke, 2020, 15(09): 934-941.
刘慧慧,姜倩梅,戴婧,刘春风. 急性缺血性卒中静脉溶栓治疗研究新进展[J]. 中国卒中杂志, 2020, 15(09): 934-941.
[1] GBD 2016 Stroke Collaborators. Global,regional,and national burden of stroke,1990-2016:asystematic analysis for the Global Burden of DiseaseStudy 2016[J]. Lancet Neurol,2019,18(5):439-458.[2] GBD 2016 Lifetime Risk of Stroke Collaborators,FEIGIN V L,NGUYEN G,et al. Global,regional,and country-specific lifetime risks of stroke,1990and 2016[J]. N Engl J Med,2018,379(25):2429-2437.[3] POWERS W J,RABINSTEIN A A,ACKERSONT,et al. Guidelines for the early management ofpatients with acute ischemic stroke:2019 updateto the 2018 guidelines for the early management ofacute ischemic stroke:a guideline for healthcareprofessionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2019,50(12):e344-e418[2020-06-30]. https://doi.org/10.1161/STR.0000000000000211.[4] National Institute of Neurological Disordersand Stroke rt-PA Stroke Study Group. Tissueplasminogen activator for acute ischemic stroke[J/OL]. N Engl J Med,1995,333:1581-1587[2020-06-30]. https://doi.org/10.1056/NEJM199512143332401.[5] MA H,CAMPBELL B C V,PARSONS M W,etal. Thrombolysis guided by perfusion imaging up to9 hours after onset of stroke[J]. N Engl J Med,2019,380(19):1795-1803.[6] CAMPBELL B C V,MA H,RINGLEB P A,etal. Extending thrombolysis to 4.5-9 h and wake-upstroke using perfusion imaging:a systematic reviewand meta-analysis of individual patient data[J].Lancet,2019,394(10193):139-147.[7] LARRUE V,VON KUMMER R,DEL ZOPPO G,et al. Hemorrhagic transformation in acute ischemicstroke. Potential contributing factors in the EuropeanCooperative Acute Stroke Study[J]. Stroke,1997,28(5):957-960.[8] ASTRUP J,SIESJÖ B K,SYMON L. Thresholds incerebral ischemia - the ischemic penumbra[J]. Stroke,1981,12(6):723-725.[9] HEISS W D,ZARO WEBER O. Validationof MRI determination of the penumbra by PETmeasurements in ischemic stroke[J]. J Nucl Med,2017,58(2):187-193.[10] KIDWELL C S,ALGER J R,SAVER J L. Beyondmismatch:evolving paradigms in imaging theischemic penumbra with multimodal magneticresonance imaging[J]. Stroke,2003,34(11):2729-2735.[11] KONSTAS A A,LEV M H. CT perfusion imagingof acute stroke:the need for arrival time,delayinsensitive,and standardized postprocessingalgorithms?[J]. Radiology,2010,254(1):22-25.[12] CHUNG J W,KIM J Y,PARK H K,et al. Impact ofthe penumbral pattern on clinical outcome in patientswith successful endovascular revascularization[J]. JStroke Cerebrovasc Dis,2017,26(2):360-367.[13] CEREDA C W,CHRISTENSEN S,CAMPBELL BC V,et al. A benchmarking tool to evaluate computertomography perfusion infarct core predictionsagainst a DWI standard[J]. J Cereb Blood FlowMetab,2016,36(10):1780-1789.[14] CAMPBELL B C V,CHRISTENSEN S,LEVI C R,et al. Cerebral blood flow is the optimal CT perfusionparameter for assessing infarct core[J]. Stroke,2011,42(12):3435-3440.[15] BIVARD A,MCELDUFF P,SPRATT N,etal. Defining the extent of irreversible brainischemia using perfusion computed tomography[J].Cerebrovasc Dis,2011,31(3):238-245.[16] WU L,WU W,TALI E T,et al. Oligemia,penumbra,infarction:understanding hypoperfusionwith neuroimaging[J]. Neuroimaging Clin N Am,2018,28(4):599-609.[17] LIN L T,BIVARD A,KRISHNAMURTHY V,etal. Whole-brain CT perfusion to quantify acuteischemic penumbra and core[J]. Radiology,2016,279(3):876-887.[18] MARTINS N,AIRES A,MENDEZ B,et al. Ghostinfarct core and admission computed tomographyperfusion:redefining the role of neuroimaging inacute ischemic stroke[J]. Interventional neurology,2018,7(6):513-521.[19] BONED S,PADRONI M,RUBIERA M,et al.Admission CT perfusion may overestimate initialinfarct core:the ghost infarct core concept[J]. JNeurointerv Surg,2017,9(1):66-69.[20] GEUSKENS R R E G,BORST J,LUCASM,et al. Characteristics of misclassified CTperfusion ischemic core in patients with acuteischemic stroke[J/OL]. PLoS One,2015,10(11):e0141571[2020-06-30]. https://doi.org/10.1371/journal.pone.0141571.[21] VAGAL A,WINTERMARK M,NAEL K,et al.Automated CT perfusion imaging for acute ischemicstroke:pearls and pitfalls for real-world use[J].Neurology,2019,93(20):888-898.[22] KUDO K,SASAKI M,YAMADA K,et al.Differences in CT perfusion maps generated bydifferent commercial software:quantitative analysisby using identical source data of acute strokepatients[J]. Radiology,2010,254(1):200-209.[23] FAHMI F,MARQUERING H A,STREEKSTRA GJ,et al. Differences in CT perfusion summary mapsfor patients with acute ischemic stroke generated by2 software packages[J]. AJNR Am J Neuroradiol,2012,33(11):2074-2080.[24] GLE?A,CHRZAN R,URBANIK A. Theeffect of software post-processing applicationson identification of the penumbra and core withinthe ischaemic region in perfusion computedtomography[J/OL]. Pol J Radiol,2019,84:e118-e125[2020-06-30]. https://doi.org/10.5114/pjr.2019.83182.[25] MOKIN M,LEVY E I,SAVER J L,et al. Predictivevalue of RAPID assessed perfusion thresholds onfinal infarct volume in SWIFT PRIME(SolitaireWith the Intention for Thrombectomy as PrimaryEndovascular Treatment)[J]. Stroke,2017,48(4):932-938.[26] AUSTEIN F,RIEDEL C,KERBY T,et al.Comparison of perfusion CT software to predict thefinal infarct volume after thrombectomy[J]. Stroke,2016,47(9):2311-2317.[27] KUDO K,CHRISTENSEN S,SASAKI M,etal. Accuracy and reliability assessment of CT andMR perfusion analysis software using a digitalphantom[J]. Radiology,2013,267(1):201-211.[28] CHEN C S,BIVARD A,LIN L T,et al. Thresholdsfor infarction vary between gray matter and whitematter in acute ischemic stroke:a CT perfusionstudy[J]. J Cereb Blood Flow Metab,2019,39(3):536-546.[29] PALLESEN L P,GERBER J,DZIALOWSKI I,et al.Diagnostic and prognostic impact of pc-ASPECTSapplied to perfusion CT in the Basilar ArteryInternational Cooperation Study[J]. J Neuroimaging,2015,25(3):384-389.[30] SPORNS P,SCHMIDT R,MINNERUP J,etal. Computed tomography perfusion improvesdiagnostic accuracy in acute posterior circulationstroke[J]. Cerebrovasc Dis,2016,41(5/6):242-247.[31] VAN DER HOEVEN E J,DANKBAAR J W,ALGRA A,et al. Additional diagnostic value ofcomputed tomography perfusion for detection ofacute ischemic stroke in the posterior circulation[J].Stroke,2015,46(4):1113-1115.[32] SCHAEFER P W,GRANT P E,GONZALEZ RG. Diffusion-weighted MR imaging of the brain[J].Radiology,2000,217(2):331-345.[33] CAMPBELL B C V,PURUSHOTHAM A,CHRISTENSEN S,et al. The infarct core is wellrepresented by the acute diffusion lesion:sustainedreversal is infrequent[J]. J Cereb Blood Flow Metab,2012,32(1):50-56.[34] LABEYRIE M A,TURC G,HESS A,et al.Diffusion lesion reversal after thrombolysis:a MRcorrelate of early neurological improvement[J].Stroke,2012,43(11):2986-2991.[35] THOMALLA G,SIMONSEN C Z,BOUTITIEF,et al. MRI-guided thrombolysis for stroke withunknown time of onset[J]. N Engl J Med,2018,379(7):611-622.[36] BOUSLAMA M,BOWEN M T,HAUSSEN D C,etal. Selection paradigms for large vessel occlusionacute ischemic stroke endovascular therapy[J].Cerebrovasc Dis,2017,44(5/6):277-284.[37] CAMPBELL B C,MITCHELL P J,KLEINIG T J,et al. Endovascular therapy for ischemic stroke withperfusion-imaging selection[J]. N Engl J Med,2015,372(11):1009-1018.[38] SAVER J L,GOYAL M,BONAFE A,et al. Stent retriever thrombectomy after intravenous t-PA vs.t-PA alone in stroke[J]. N Engl J Med,2015,372(24):2285-2295.[39] ALBERS G W,MARKS M P,KEMP S,et al.Thrombectomy for stroke at 6 to 16 hours withselection by perfusion imaging[J]. N Engl J Med,2018,378(8):708-718.[40] RINGLEB P,BENDSZUS M,BLUHMKI E,etal. Extending the time window for intravenousthrombolysis in acute ischemic stroke using magneticresonance imaging-based patient selection[J]. Int JStroke,2019,14(5):483-490.[41] NOGUEIRA R G,JADHAV A P,HAUSSEN D C,et al. Thrombectomy 6 to 24 hours after stroke witha mismatch between deficit and infarct[J]. N Engl JMed,2018,378(1):11-21.[42] KOGA M,YAMAMOTO H,INOUE M,etal. Thrombolysis with alteplase at 0.6 mg/kg forstroke with unknown time of onset:a randomizedcontrolled trial[J]. Stroke,2020,51(5):1530-1538.[43] YU W G,JIANG W J. A simple imaging guide forendovascular thrombectomy in acute ischemic stroke:from time window to perfusion mismatch andbeyond[J/OL]. Front Neurol,2019,10:502[2020-06-30]. https://doi.org/10.3389/fneur.2019.00502.[44] KENT D M,HILL M D,RUTHAZER R,et al."Clinical-CT mismatch" and the response to systemicthrombolytic therapy in acute ischemic stroke[J].Stroke,2005,36(8):1695-1699.[45] MESSÉ S R,KASNER S E,CHALELA J A,et al.CT-NIHSS mismatch does not correlate with MRIdiffusion-perfusion mismatch[J]. Stroke,2007,38(7):2079-2084.[46] BONAVENTURA A,MONTECUCCO F,DALLEGRI F. Update on the effects of treatmentwith recombinant tissue-type plasminogen activator(rt-PA)in acute ischemic stroke[J]. Expert Opin BiolTher,2016,16(11):1323-1340.[47] LOGALLO N,KVISTAD C E,NACU A,et al.The Norwegian tenecteplase stroke trial(NORTEST):randomised controlled trial of tenecteplasevs. alteplase in acute ischaemic stroke[J/OL]. BMCNeurol,2014,14:106[2020-06-30]. https://doi.org/10.1186/1471-2377-14-106.[48] KVISTAD C E,NOVOTNY V,KURZ M W,et al.Safety and outcomes of tenecteplase in moderateand severe ischemic stroke[J]. Stroke,2019,50(5):1279-1281.[49] CAMPBELL B C,MITCHELL P J,CHURILOVL,et al. Tenecteplase versus alteplase beforeendovascular thrombectomy(EXTEND-IA TNK):a multicenter,randomized,controlled study[J]. Int JStroke,2018,13(3):328-334.[50] CAMPBELL B C V,MITCHELL P J,CHURILOVL,et al. Determining the optimal dose oftenecteplase before endovascular therapy forischemic stroke(EXTEND-IA TNK Part 2):amulticenter,randomized,controlled study[J]. Int JStroke,2019,15(5):567-572.[51] YANG P F,ZHANG Y W,ZHANG L,et al.Endovascular Thrombectomy with or withoutintravenous alteplase in acute stroke[J]. N Engl JMed,2020,382(21):1981-1993. |
[1] | LU Yan, YANG Baorong, HUANG Xiangping, YANG Guangui, CHEN Shengwen, LI Jianrong, ZENG Xiaoming. MRI-Guided Thrombolysis beyond Time Window in Acute Ischemic Stroke in a County-Level Hospital: A Case-Control Study [J]. Chinese Journal of Stroke, 2022, 17(12): 1321-1326. |
[2] | XIANG Wei, XU Luyao, ZHANG Manman, WEI Hongchun, LIANG Zhigang. The Frequency and Influencing Factors of Asymmetrical Prominent Veins Sign on Susceptibility-Weighted Imaging in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1097-1102. |
[3] | ZHANG Boyu, GUO Yucheng, CUI Yuxia, LI Yingli, LYU Yumei. Seeking Medical Services Decision-Making Status and Relevant Influencing Factors in Patients with Acute Ischemic Stroke: A Review [J]. Chinese Journal of Stroke, 2022, 17(10): 1127-1132. |
[4] | WU Tingting, LIU Yafei, YAN Shixi, WU Yiping, ZHANG Zhongbo, ZAHNG Hanfei, FANG Pinping. Application of “Internet Plus” in Emergency Care of Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1133-1138. |
[5] | ZHENG Wei, ZHAI Huazheng, CHEN Mengmeng, WANG Jingye. Efficacy and Safety of Direct Thrombectomy versus Bridging Therapy for Acute Ischemic Stroke: A Meta-Analysis [J]. Chinese Journal of Stroke, 2022, 17(07): 720-729. |
[6] | ZHOU Juan, TAN Yunbin, WANG Tiejun, SHI Fuming, YU Ping. Incidence and Influencing Factors of Anxiety and Depression in Caregivers of Patients with Acute Ischemic Stroke during Hospitalization [J]. Chinese Journal of Stroke, 2022, 17(07): 764-768. |
[7] | XUAN Guiying, FAN Caili, XUAN Lixia, ZHAO Qianqian, LI Xuemei. Analysis of Reasons for Loss of Follow-up among Acute Ischemic Stroke Patients during the COVID-19 Pandemic [J]. Chinese Journal of Stroke, 2022, 17(06): 648-652. |
[8] | ZHANG Dong, LI Zhizhang, MA Ruinan, YUE Yunhua. Correlation between Stress Hyperglycemia Ratio and Clinical Prognosis of Patients with Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(05): 483-490. |
[9] | HUANG Yan, FU Xuejun, SHI Huijie, ZOU Liangyu. Correlation between Triglyceride-Glucose Index and Neurological Function Impairment after Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(03): 251-257. |
[10] | LIU Zhong, LIU Yuanyuan, XU Shaofeng, GUO Wei, KANG Hai. Correlation Analysis of Systemic Immune-Inflammatory Index with Severity and Prognosis of Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(03): 285-291. |
[11] | GUO Songtao, E Bu, LI Zhiqiang, JIANG Hao, XU Yuzhu, SUN Jian, SHI Jianmin, WU Xi, GUO Wei. Advances in the Application of 5G Mobile Stroke Unit [J]. Chinese Journal of Stroke, 2022, 17(02): 113-117. |
[12] | HUO Xiaochuan, LI Xiaoqing, MIAO Zhongrong, Expert Committee for Neurointervention Quality Control of National Center for Healthcare Quality Management in Neurological Diseases, Endovascular Treatment Working Committee of National Action for Quality Improvement of Acute Cerebral Infarction Reperfusion Therapy. A Survey of Current Practice in Acute Ischemic Stroke Endovascular Treatment in China in 2020 [J]. Chinese Journal of Stroke, 2022, 17(01): 56-65. |
[13] | CHEN Zhengyu, CHEN Guofang, CHEN Tong, MA Dongjiao. Influencing Factors of Leukoaraiosis at Different Brain Regions in Patients with Intravenous Thrombolysis for Acute Ischemic Strok [J]. Chinese Journal of Stroke, 2021, 16(12): 1248-1252. |
[14] | CAO Shuangshuang, ZHANG Xiaoyan, WANG Jianwei, ZHAO Lei, CHEN Hongbing, WANG Mingyu. The Related Factors of Early Neurological Deterioration after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2021, 16(12): 1253-1258. |
[15] | ZHANG Xin-Miao, WANG Chun-Juan, YANG Xin, GU Hong-Qiu, JIANG Ying-Yu, WANG Yi-Long, ZHAO Xing-Quan, LI Zi-Xiao, WANG Yong-Jun. Safety of Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Antithrombotic Therapy before Stroke Onset [J]. Chinese Journal of Stroke, 2021, 16(11): 1110-1114. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||